Literature DB >> 1655284

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.

J Pelletier1, W Bruening, C E Kashtan, S M Mauer, J C Manivel, J E Striegel, D C Houghton, C Junien, R Habib, L Fouser.   

Abstract

Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms' tumor (nephroblastoma). To investigate its possible role, we have analyzed the coding exons of the Wilms' tumor suppressor gene (WT1) for germline mutations. In ten independent cases of Denys-Drash syndrome, point mutations in the zinc finger domains of one WT1 gene copy were found. Nine of these mutations are found within exon 9 (zinc finger III); the remaining mutation is in exon 8 (zinc finger II). These mutations directly affect DNA sequence recognition. In two families analyzed, the mutations were shown to arise de novo. Wilms' tumors from three individuals and one juvenile granulosa cell tumor demonstrate reduction to homozygosity for the mutated WT1 allele. Our results provide evidence of a direct role for WT1 in Denys-Drash syndrome and thus urogenital system development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655284     DOI: 10.1016/0092-8674(91)90194-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  190 in total

1.  Induction of a bystander mutagenic effect of alpha particles in mammalian cells.

Authors:  H Zhou; G Randers-Pehrson; C A Waldren; D Vannais; E J Hall; T K Hei
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells.

Authors:  D A Haber; H T Timmers; J Pelletier; P A Sharp; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  The molecular basis of nephrogenesis and congenital kidney disease.

Authors:  J Bard
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

4.  Should bilateral nephrectomy be carried out in all children with diffuse mesangial sclerosis prior to renal transplantation in view of the connection with Drash syndrome and therefore the risk of a Wilms' tumour developing?

Authors:  M F Gagnadoux; R Habib
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

5.  A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis.

Authors:  N Groves; P N Baird; A Hogg; J K Cowell
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

Review 6.  Educational paper: the podocytopathies.

Authors:  Anja K Büscher; Stefanie Weber
Journal:  Eur J Pediatr       Date:  2012-01-13       Impact factor: 3.183

Review 7.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 8.  Pediatric oncology.

Authors:  Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2010-08       Impact factor: 2.754

Review 9.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

10.  Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile.

Authors:  Colin G Miles; Joan Slight; Lee Spraggon; Maureen O'Sullivan; Charles Patek; Nicholas D Hastie
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.